BBIO

SEC source: 0000950170-25-089642 · ownership.xml · derivative · entry 3

Scott Randal W. · CIK 0001337801 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,425

Underlying: Common Stock · 8,425 shares

Expires 2035-06-19

F3 · derivative.exercise_date: One-third of the shares underlying the stock option will vest each year after June 20, 2025, such that all of the underlying shares will be vested on June 20, 2028, subject to the Reporting Person's continued service on the Issuer's board of directors.

SEC source: 0000950170-25-089642 · ownership.xml · nonDerivative · entry 1

Scott Randal W. · CIK 0001337801 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,589

F1 · kind: Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. One-third of the RSUs will vest each year after June 20, 2025, such that all of the units will be vested on June 20, 2028, subject to the Reporting Person's continued service on the Issuer's board of directors.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

SEC source: 0000950170-25-084914 · ownership.xml · derivative · entry 4

Valantine Hannah · CIK 0001855608 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,334

Underlying: Common Stock · 4,292 shares

Expires 2033-06-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 5, 2024.

F2 · derivative.exercise_date: The stock option vests and becomes exercisable in three annual installments starting on June 22, 2023 and ending on June 22, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors.

SEC source: 0000950170-25-084914 · ownership.xml · nonDerivative · entry 2

Valantine Hannah · CIK 0001855608 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,764

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 5, 2024.

SEC source: 0000950170-25-084914 · ownership.xml · nonDerivative · entry 1

Valantine Hannah · CIK 0001855608 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,056

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 5, 2024.

SEC source: 0000950170-25-075425 · ownership.xml · nonDerivative · entry 5

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 4,798,447

F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024.

F6 · price: Represents the weighted average sale price of the shares sold from $33.02 to $33.66 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F7 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

SEC source: 0000950170-25-075425 · ownership.xml · nonDerivative · entry 4

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 217,404

F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024.

F5 · price: Represents the weighted average sale price of the shares sold from $33.72 to $33.79 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

SEC source: 0000950170-25-075425 · ownership.xml · nonDerivative · entry 3

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 217,804

F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024.

F4 · price: Represents the weighted average sale price of the shares sold from $32.72 to $33.71 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

SEC source: 0000950170-25-075340 · ownership.xml · nonDerivative · entry 1

Apuli Maricel · CIK 0002058197 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,859

F1 · shares: Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 9,408 shares of Common Stock underlying the Reporting Person's Restricted Stock Units.

SEC source: 0000950170-25-075346 · ownership.xml · nonDerivative · entry 1

Trimarchi Thomas · CIK 0002030813 · President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 501,988

F1 · shares: Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 38,545 shares of Common Stock underlying the Reporting Person's Restricted Stock Units.

SEC source: 0000950170-25-075425 · ownership.xml · derivative · entry 9

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 173,307

Underlying: Common Stock · 11,553 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F10 · derivative.exercise_date: The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2025. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

F10 · derivative.expiration_date: The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2025. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

SEC source: 0000950170-25-075425 · ownership.xml · derivative · entry 8

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 215,592

Underlying: Common Stock · 19,599 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F9 · derivative.exercise_date: The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

F9 · derivative.expiration_date: The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

SEC source: 0000950170-25-075425 · ownership.xml · derivative · entry 7

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 234,808

Underlying: Common Stock · 33,544 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F8 · derivative.exercise_date: The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

F8 · derivative.expiration_date: The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

SEC source: 0000950170-25-075425 · ownership.xml · nonDerivative · entry 2

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 243,560

F2 · shares: Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 64,696 shares of Common Stock underlying the Reporting Person's RSUs.

SEC source: 0000950170-25-075425 · ownership.xml · nonDerivative · entry 1

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 276,414

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

SEC source: 0001140361-25-019003 · form4.xml · nonDerivative · entry 1

KKR Genetic Disorder L.P. · CIK 0001780408 · 10% owner

KKR Genetic Disorder GP LLC · CIK 0001780428 · 10% owner

KKR Group Partnership L.P. · CIK 0001472698 · 10% owner

KKR Group Holdings Corp. · CIK 0001743754 · 10% owner

KKR Group Co. Inc. · CIK 0001932162 · 10% owner

KKR & Co. Inc. · CIK 0001404912 · 10% owner

KKR Management LLP · CIK 0001472694 · 10% owner

KRAVIS HENRY R · CIK 0001081714 · 10% owner

ROBERTS GEORGE R · CIK 0001081715 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 13,260,971

F1 · price: Reflects the sale of 6,000,000 shares of common stock of BridgeBio Pharma, Inc. (the "Issuer"), par value $0.001 per share (the "Common Stock"), by KKR Genetic Disorder L.P. in a block sale at a price per share of $34.20 pursuant to Rule 144 of the Securities Act of 1933, as amended.

F2 · ownership.nature: The shares of Common Stock are held by KKR Genetic Disorder L.P. KKR Genetic Disorder GP LLC is the general partner of KKR Genetic Disorder L.P. KKR Group Partnership L.P. is the sole member of KKR Genetic Disorder GP LLC. KKR Group Holdings Corp. is the general partner of KKR Group Partnership L.P. KKR Group Co. Inc. is the sole shareholder of KKR Group Holdings Corp. KKR & Co. Inc. is the sole shareholder of KKR Group Co. Inc. KKR Management LLP is the Series I preferred stockholder of KKR & Co. Inc. Messrs. Henry R. Kravis and George R. Roberts are the founding partners of KKR Management LLP but disclaim beneficial ownership of the reported securities.

F3 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein.

SEC source: 0000950170-25-068335 · ownership.xml · nonDerivative · entry 2

MCCORMICK FRANK · CIK 0001257809 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,686

SEC source: 0000950170-25-068335 · ownership.xml · nonDerivative · entry 1

MCCORMICK FRANK · CIK 0001257809 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,686

SEC source: 0000950170-25-064567 · ownership.xml · nonDerivative · entry 1

Apuli Maricel · CIK 0002058197 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,639

SEC source: 0000950170-25-064558 · ownership.xml · nonDerivative · entry 1

Lo Andrew · CIK 0001679076 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Andrew W. Lo and Nancy N. Lo JTWROS

Disclosed balance after: 105,583

F1 · price: Represents the weighted average sale price of the shares sold from $38.155 to $38.75 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

SEC source: 0000950170-25-058102 · ownership.xml · nonDerivative · entry 1

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 4,873,447

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024.

F2 · price: Represents the weighted average sale price of the shares sold from $33.56 to $34.44 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

SEC source: 0000950170-25-054883 · ownership.xml · derivative · entry 3

Ellis Andrea · CIK 0001877680 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,921

Underlying: Common Stock · 10,000 shares

Expires 2032-06-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 30, 2024.

F2 · derivative.exercise_date: The stock option vests and becomes exercisable in three annual installments starting on June 22, 2023 and ending on June 22, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors.

SEC source: 0000950170-25-054883 · ownership.xml · nonDerivative · entry 2

Ellis Andrea · CIK 0001877680 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,000

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 30, 2024.

SEC source: 0000950170-25-054883 · ownership.xml · nonDerivative · entry 1

Ellis Andrea · CIK 0001877680 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 30, 2024.

SEC source: 0000950170-25-050584 · ownership.xml · derivative · entry 3

Ellis Andrea · CIK 0001877680 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,921

Underlying: Common Stock · 30,000 shares

Expires 2032-06-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 30, 2024.

F2 · derivative.exercise_date: The stock option vests and becomes exercisable in three annual installments starting on June 22, 2023 and ending on June 22, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors.

SEC source: 0000950170-25-050584 · ownership.xml · nonDerivative · entry 2

Ellis Andrea · CIK 0001877680 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,000

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 30, 2024.

SEC source: 0000950170-25-050584 · ownership.xml · nonDerivative · entry 1

Ellis Andrea · CIK 0001877680 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 30, 2024.

SEC source: 0000950170-25-046171 · ownership.xml · nonDerivative · entry 1

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 4,948,447

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024.

F2 · price: Represents the weighted average sale price of the shares sold from $36.55 to $37.53 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

SEC source: 0000950170-25-043376 · ownership.xml · nonDerivative · entry 1

Apuli Maricel · CIK 0002058197 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,665

F1 · kind: Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs shall vest with respect to 1/16th of the underlying shares on May 16, 2025, and as to 1/16th of the underlying shares each quarter thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

SEC source: 0000950170-25-043403 · ownership.xml · nonDerivative · entry 1

Trimarchi Thomas · CIK 0002030813 · President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 523,305

F1 · kind: Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs shall vest with respect to 1/16th of the underlying shares on May 16, 2025, and as to 1/16th of the underlying shares each quarter thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

SEC source: 0000950170-25-043379 · ownership.xml · derivative · entry 2

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 184,860

Underlying: Common Stock · 184,860 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: The RSUs vest with respect to 1/16th of the underlying shares on May 16, 2025, and thereafter, 1/16th of the underlying shares will vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

F3 · derivative.expiration_date: The RSUs vest with respect to 1/16th of the underlying shares on May 16, 2025, and thereafter, 1/16th of the underlying shares will vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

SEC source: 0000950170-25-043379 · ownership.xml · derivative · entry 1

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,208

Underlying: Common Stock · 71,208 shares

Expires 2035-03-18

F1 · derivative.exercise_date: 1/16th of the shares subject to this option vest and become exercisable on May 16, 2025, and thereafter, 1/16th of the shares subject to this option will vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date.

SEC source: 0000950170-25-036420 · ownership.xml · derivative · entry 4

Valantine Hannah · CIK 0001855608 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,626

Underlying: Common Stock · 12,875 shares

Expires 2033-06-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 5, 2024.

F3 · derivative.exercise_date: The stock option vests in three annual installments starting on June 21, 2024 and ending on June 21, 2026, subject to the Reporting Person's continued service on the Issuer's board of directors.

SEC source: 0000950170-25-036420 · ownership.xml · nonDerivative · entry 2

Valantine Hannah · CIK 0001855608 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,764

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 5, 2024.

F2 · price: Represents the weighted average sale price of the shares sold from $32.17 to $33.01 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

SEC source: 0000950170-25-036420 · ownership.xml · nonDerivative · entry 1

Valantine Hannah · CIK 0001855608 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,639

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 5, 2024.

SEC source: 0001140361-25-007699 · form4.xml · nonDerivative · entry 1

KKR Genetic Disorder L.P. · CIK 0001780408 · 10% owner

KKR Genetic Disorder GP LLC · CIK 0001780428 · 10% owner

KKR Group Partnership L.P. · CIK 0001472698 · 10% owner

KKR Group Holdings Corp. · CIK 0001743754 · 10% owner

KKR Group Co. Inc. · CIK 0001932162 · 10% owner

KKR & Co. Inc. · CIK 0001404912 · 10% owner

KKR Management LLP · CIK 0001472694 · 10% owner

KRAVIS HENRY R · CIK 0001081714 · 10% owner

ROBERTS GEORGE R · CIK 0001081715 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 19,260,971

F1 · price: Reflects the sale of 6,000,000 shares of common stock of BridgeBio Pharma, Inc. (the "Issuer"), par value $0.001 per share (the "Common Stock"), by KKR Genetic Disorder L.P. in a block sale at a price per share of $32.96 pursuant to Rule 144 of the Securities Act of 1933, as amended.

F2 · ownership.nature: The shares of Common Stock are held by KKR Genetic Disorder L.P. KKR Genetic Disorder GP LLC is the general partner of KKR Genetic Disorder L.P. KKR Group Partnership L.P. is the sole member of KKR Genetic Disorder GP LLC. KKR Group Holdings Corp. is the general partner of KKR Group Partnership L.P. KKR Group Co. Inc. is the sole shareholder of KKR Group Holdings Corp. KKR & Co. Inc. is the sole shareholder of KKR Group Co. Inc. KKR Management LLP is the Series I preferred stockholder of KKR & Co. Inc. Messrs. Henry R. Kravis and George R. Roberts are the founding partners of KKR Management LLP but disclaim beneficial ownership of the reported securities.

F3 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein.

SEC source: 0000950170-25-029262 · ownership.xml · derivative · entry 4

STEPHENSON BRIAN C · CIK 0001780030 · CFO and Treasurer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 440,170

Underlying: Common Stock · 8,500 shares

Expires 2029-06-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024.

F3 · derivative.exercise_date: The shares subject to this option vested in 48 equal monthly installments from June 26, 2019 to June 26, 2023.

SEC source: 0000950170-25-029262 · ownership.xml · nonDerivative · entry 3

STEPHENSON BRIAN C · CIK 0001780030 · CFO and Treasurer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 102,464

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024.

SEC source: 0000950170-25-029262 · ownership.xml · nonDerivative · entry 2

STEPHENSON BRIAN C · CIK 0001780030 · CFO and Treasurer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 102,564

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024.

F2 · price: Represents the weighted average sale price of the shares sold from $32.63 to $33.53 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

SEC source: 0000950170-25-029262 · ownership.xml · nonDerivative · entry 1

STEPHENSON BRIAN C · CIK 0001780030 · CFO and Treasurer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 110,964

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024.

SEC source: 0000950170-25-029228 · ownership.xml · nonDerivative · entry 2

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 5,023,447

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024.

F4 · price: Represents the weighted average sale price of the shares sold from $33.635 to $34.18 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

SEC source: 0000950170-25-029228 · ownership.xml · nonDerivative · entry 1

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 5,060,548

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024.

F2 · price: Represents the weighted average sale price of the shares sold from $32.63 to $33.61 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

SEC source: 0000950170-25-023630 · ownership.xml · nonDerivative · entry 3

STEPHENSON BRIAN C · CIK 0001780030 · Secretary, Treasurer & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 102,464

F4 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024.

F5 · price: Represents the weighted average sale price of the shares sold from $35.57 to $36.48 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

SEC source: 0000950170-25-023625 · ownership.xml · nonDerivative · entry 4

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 211,718

F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024.

SEC source: 0000950170-25-023625 · ownership.xml · nonDerivative · entry 3

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 211,794

F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024.

F4 · price: Represents the weighted average sale price of the shares sold from $35.50 to $36.48 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

SEC source: 0000950170-25-023632 · ownership.xml · nonDerivative · entry 1

Trimarchi Thomas · CIK 0002030813 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 414,205

F1 · shares: Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax obligation in connection with the vesting of 32,431 shares of Common Stock underlying the Reporting Person's Restricted Stock Units.

SEC source: 0000950170-25-023630 · ownership.xml · derivative · entry 7

STEPHENSON BRIAN C · CIK 0001780030 · Secretary, Treasurer & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 80,459

Underlying: Common Stock · 6,705 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F9 · derivative.exercise_date: The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

F9 · derivative.expiration_date: The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

SEC source: 0000950170-25-023630 · ownership.xml · derivative · entry 6

STEPHENSON BRIAN C · CIK 0001780030 · Secretary, Treasurer & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 138,947

Underlying: Common Stock · 17,368 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F8 · derivative.exercise_date: The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

F8 · derivative.expiration_date: The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

SEC source: 0000950170-25-023630 · ownership.xml · derivative · entry 5

STEPHENSON BRIAN C · CIK 0001780030 · Secretary, Treasurer & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,840

Underlying: Common Stock · 946 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F7 · derivative.exercise_date: The RSUs vested with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

F7 · derivative.expiration_date: The RSUs vested with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

SEC source: 0000950170-25-023630 · ownership.xml · derivative · entry 4

STEPHENSON BRIAN C · CIK 0001780030 · Secretary, Treasurer & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 779 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F6 · derivative.exercise_date: The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2021. Thereafter, 1/16th of the underlying shares vested on a quarterly basis. The RSUs have no expiration date.

F6 · derivative.expiration_date: The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2021. Thereafter, 1/16th of the underlying shares vested on a quarterly basis. The RSUs have no expiration date.